Literature DB >> 15534259

Different progression rates for deep white matter hyperintensities in elderly men and women.

D M J van den Heuvel1, F Admiraal-Behloul, V H ten Dam, H Olofsen, E L E M Bollen, H M Murray, G J Blauw, R G J Westendorp, A J M de Craen, M A van Buchem.   

Abstract

The authors investigated the progression of white matter hyperintensities (WMHs) in a large population of elderly men and women. After 3 years of follow-up, women had accumulated approximately twice as much deep WMH (DWMH) as men. The progression of periventricular WMH was the same for men and women. Gender differences may affect the pathogenesis of DWMH, which in turn may result in different clinical consequences in women.

Entities:  

Mesh:

Year:  2004        PMID: 15534259     DOI: 10.1212/01.wnl.0000143058.40388.44

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  31 in total

1.  Modifiable cardiovascular risk factors and axial motor impairments in Parkinson disease.

Authors:  Vikas Kotagal; Roger L Albin; Martijn L T M Müller; Robert A Koeppe; Kirk A Frey; Nicolaas I Bohnen
Journal:  Neurology       Date:  2014-03-28       Impact factor: 9.910

2.  Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities.

Authors:  Shanna L Burke; Tianyan Hu; Nicole M Fava; Tan Li; Miriam J Rodriguez; Katie L Schuldiner; Aaron Burgess; Angela Laird
Journal:  J Women Aging       Date:  2018-01-10

3.  Longitudinal follow-up of individual white matter hyperintensities in a large cohort of elderly.

Authors:  Pauline Maillard; Fabrice Crivello; Carole Dufouil; Nathalie Tzourio-Mazoyer; Christophe Tzourio; Bernard Mazoyer
Journal:  Neuroradiology       Date:  2009-01-13       Impact factor: 2.804

Review 4.  Blood and CSF biomarkers in brain subcortical ischemic vascular disease: Involved pathways and clinical applicability.

Authors:  A Vilar-Bergua; I Riba-Llena; C Nafría; A Bustamante; V Llombart; P Delgado; J Montaner
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

5.  Gender differences in outcomes after ischemic stroke: role of ischemic lesion volume and intracranial large-artery occlusion.

Authors:  Gisele S Silva; Fabricio O Lima; Erica C S Camargo; Wade S Smith; Michael H Lev; Gordon J Harris; Elkan F Halpern; Walter Koroshetz; Karen L Furie
Journal:  Cerebrovasc Dis       Date:  2010-08-24       Impact factor: 2.762

6.  Ultrasound measurements of brain tissue pulsatility correlate with the volume of MRI white-matter hyperintensity.

Authors:  Redouane Ternifi; Xavier Cazals; Thomas Desmidt; Frédéric Andersson; Vincent Camus; Jean-Philippe Cottier; Frédéric Patat; Jean-Pierre Remenieras
Journal:  J Cereb Blood Flow Metab       Date:  2014-04-09       Impact factor: 6.200

7.  Higher Aortic Stiffness Is Associated With Lower Global Cerebrovascular Reserve Among Older Humans.

Authors:  Lyndsey E DuBose; Laura L Boles Ponto; David J Moser; Emily Harlynn; Leah Reierson; Gary L Pierce
Journal:  Hypertension       Date:  2018-06-18       Impact factor: 10.190

8.  Effects of hormone replacement therapy on magnetic resonance imaging of brain parenchyma hyperintensities in postmenopausal women.

Authors:  Yan-Yong Liu; Ling Hu; Chao Ji; Dong-Wen Chen; Xi Shen; Nan Yang; Yun Yue; Jing-Mei Jiang; Xia Hong; Qin-Sheng Ge; Ping-Ping Zuo
Journal:  Acta Pharmacol Sin       Date:  2009-07       Impact factor: 6.150

9.  White matter hyperintensities in the forties: their prevalence and topography in an epidemiological sample aged 44-48.

Authors:  Wei Wen; Perminder S Sachdev; Jason J Li; Xiaohua Chen; Kaarin J Anstey
Journal:  Hum Brain Mapp       Date:  2009-04       Impact factor: 5.038

10.  White Matter Hyperintensity-Associated Blood-Brain Barrier Disruption and Vascular Risk Factors.

Authors:  Nidhi Gupta; Alexis N Simpkins; Emi Hitomi; Christian Dias; Richard Leigh
Journal:  J Stroke Cerebrovasc Dis       Date:  2017-10-31       Impact factor: 2.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.